Development of Whole-Cell Biosensors for Screening of Peptidoglycan-Targeting Antibiotics in a Gram-Negative Bacterium

Appl Environ Microbiol. 2022 Sep 22;88(18):e0084622. doi: 10.1128/aem.00846-22. Epub 2022 Aug 30.

Abstract

There is an urgent need to develop novel antibiotics since antibiotic resistance is an increasingly serious threat to global public health. Whole-cell biosensors are one of the promising strategies for new antibiotic discovery. The peptidoglycan (PG) of the bacterial cell wall is one of the most important targets for antibiotics. However, the biosensors for the detection of PG-targeting antibiotics in Gram-negative bacteria have not been developed, mainly because of the lack of the regulatory systems that sense and respond to PG stress. Recently, we identified a novel two-component signal transduction system (PghKR) that is responsible for sensing and responding to PG damage in the Gram-negative bacterium Shewanella oneidensis. Based on this system, we developed biosensors for the detection of PG-targeting antibiotics. Using ampicillin as an inducer for PG stress and the bacterial luciferase LuxCDABE as the reporter, we found that the PghKR biosensors are specific to antibiotics targeting PG synthesis, including β-lactams, vancomycin, and d-cycloserine. Deletion of genes encoding PG permease AmpG and β-lactamase BlaA improves the sensitivity of the biosensors substantially. The PghKR biosensor in the background of ΔblaA is also functional on agar plates, providing a simple method for screening bacteria that produce PG-targeting antibiotics. IMPORTANCE The growing problem of antibiotic resistance in Gram-negative bacteria urgently needs new strategies so that researchers can develop novel antibiotics. Microbial whole-cell biosensors are capable of sensing various stimuli with a quantifiable output and show tremendous potential for the discovery of novel antibiotics. As the Achilles' heel of bacteria, the synthesis of the peptidoglycan (PG) is targeted by many antibiotics. However, the regulatory systems that sense and respond to PG-targeting stress in Gram-negative bacteria are reported rarely, restricting the development of biosensors for the detection of PG-targeting antibiotics. In this study, we developed a highly sensitive and specific biosensor based on a novel two-component system in the Gram-negative bacterium Shewanella oneidensis that is responsible for the sensing and responding to PG stress. Our biosensors have great potential for discovering novel antibiotics and determining the mode of action of antibiotics.

Keywords: antibiotics; drug discovery; peptidoglycan; two-component system; whole-cell biosensor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agar
  • Ampicillin
  • Anti-Bacterial Agents / pharmacology
  • Biosensing Techniques*
  • Cell Wall / metabolism
  • Cycloserine
  • Gram-Negative Bacteria / genetics
  • Gram-Negative Bacteria / metabolism
  • Luciferases, Bacterial
  • Membrane Transport Proteins
  • Peptidoglycan / metabolism
  • Shewanella* / genetics
  • Shewanella* / metabolism
  • Vancomycin
  • beta-Lactamases / genetics
  • beta-Lactams / pharmacology

Substances

  • Anti-Bacterial Agents
  • Membrane Transport Proteins
  • Peptidoglycan
  • beta-Lactams
  • Vancomycin
  • Ampicillin
  • Agar
  • Cycloserine
  • Luciferases, Bacterial
  • beta-Lactamases

Supplementary concepts

  • Shewanella oneidensis